How to bid in this country: portals, deadlines, thresholds →
Open framework agreement on pharmaceutical discounts pursuant to Section 130a (8) SGB V with open accession at any time, so-called admission model 2026-03
Offene Rahmenvereinbarung über Arzneimittelrabatte gemäß § 130a Abs.8 SGB V mit jederzeitiger Beitrittsmöglichkeit, sog. Zulassungsmodell 2026-03 — original title
Your path to submission
- Deadline: 5 February 2028 at 23:59 — 462 days left.
- You submit on Vergabemarktplatz (cosinex) — not here and not by e-mail. ↗ Free bidder account on the cosinex platform required (created instantly); offers go through the bidding tool, usually plain text form suffices — no qualified signature. Sort out account and signature first — not on submission day.
- Offer and evidence in: German.
- Collect your evidence — use the eligibility analysis on this page: it lists the requirements and, for known certificates, how to get them.
What the buyer is looking for
This notice is intended to conclude agreements with pharmaceutical companies within the meaning of Section 130a(8) sentence 1 SGB V. The invitation to participate is addressed only to pharmaceutical entrepreneurs or employee groups of pharmaceutical entrepreneurs within the meaning of Section 4(18) of the German Medicines Act. It is not an open procedure pursuant to § 15 VgV in conjunction with § 119(3) GWB, but a publication of the invitation to conclude/join/discount contracts with conditions that are fixed and non-negotiable for all participants, including the amount of the discount. Contractual partners may become an unlimited number of pharmaceutical entrepreneurs or employee groups of pharmaceutical entrepreneurs within the meaning of Section 4(18) of the Pharmaceuticals Act. The cancellation of procedure 2026-03 of the original publication (822904-2025 of 11.12.2025) and thus the cancellation of all lots as of 30.06.2026 is hereby announced.
Contract
Type of service
Clement What the numbers say about this buyer
- In this sector the buyer awards roughly every month (323 awards, most recently June 2026) — by that rhythm the next award was due around July 2026. The last award went to Pharmazeutische Unternehmen.n = 323
- 49% of this buyer's awards went to companies that had already won here before (562 awards since 2018, spread over 289 companies). That is well below the sector norm (62%) — this buyer switches suppliers more often than others.n = 562 awards since 2018
- The award came in at a median 67% of the estimated value (5 awards with both estimate and value) — pricing at the estimate is usually too high here. Sector: 87%.n = 5
- The median procedure drew just one bid (539 procedures with a bid count); 67% ended with a single bidder. Sector: median 2 bids.n = 539
- Across 70 procedures with structured selection criteria, this buyer most often required: Quality management (65 of 70), Trade register enrolment (65 of 70), References: services (4 of 70).n = 70
From this buyer's documented awards; comparison values from the same sector and country. Not a forecast, not legal advice. As of 01/11/2026.
What you must prove — eligibility criteria
Tender documents — direct download
Part of a larger project
- sog. Zulassungsmodell 2025-01Deadline 5 Nov
- sog. Zulassungsmodell 2025-03Deadline 5 Mar
- sog. Zulassungsmodell 2025-04Deadline 5 Apr
- sog. Zulassungsmodell 2025-05Deadline 5 May
- sog. Zulassungsmodell 2025-06Deadline 5 Jun
- sog. Zulassungsmodell 2025-07Deadline 5 Jul
- sog. Zulassungsmodell 2025-08Deadline 5 Aug
- sog. Zulassungsmodell 2025-09Deadline 5 Sept
- sog. Zulassungsmodell 2025-10Deadline 5 Oct
- sog. Zulassungsmodell 2026-01Deadline 5 Dec
- sog. Zulassungsmodell 2026-02Deadline 5 Jan
- sog. Zulassungsmodell 2026-03Deadline 5 Febthis lot
- sog. Zulassungsmodell 2026-04Deadline 5 Mar
- sog. Zulassungsmodell 2026-05Deadline 5 Apr
- sog. Zulassungsmodell 2026-06Deadline 5 Apr
- sog. Zulassungsmodell 2026-07Deadline 5 May
- sog. Zulassungsmodell 2026-08Deadline 5 Jun
- sog. Zulassungsmodell 2026-09Deadline 5 Jul
- sog. Zulassungsmodell 2026-10Deadline 5 Aug
- sog. Zulassungsmodell 2026-11Deadline 5 Sept
- sog. Zulassungsmodell 2026-12Deadline 5 Oct
Who has won at this buyer so far
Across all contract types of this buyer — not just this sector. A city buys software and fire engines through the same purchasing office.
| Company | Awards | Period |
|---|---|---|
| Aliud Pharma GmbH · Laichingen | 26 | 2012–2023 |
| Aristo Pharma GmbH · Berlin | 26 | 2012–2022 |
| Hexal AG · Holzkirchen | 20 | 2012–2023 |
| Glenmark Arzneimittel GmbH · Gröbenzell | 14 | 2012–2023 |
| axicorp Pharma B.V. · EC Den Haag | 13 | 2019–2023 |
How often this buyer tenders this kind of work
Tactics
When this buyer has awarded in this sector, usually 41 or more bids came in. Many compete here — price and references decide. (Based on 962 completed awards — not a statement about this procedure.)
This procedure allows 621 days between publication and deadline — typical in this country is 32 (median of 20,496 procedures). Much more generous than usual — time for a thorough bid rather than a quick one.
Foreign bidders
In Germany · Medical equipment & pharma, 270 contracts went to foreign companies over the last 3 years (of 22,355 recorded awards) — mostly from Austria, Netherlands, France.
Submission language: German.
How to bid
Don't miss the next one
Friedrich finds tenders like this for you — every morning at 7:30, each one checked by Claude (Anthropic) for fit, and he learns from your feedback what your company really does.
Register now